Spebrutinib has been used in trials studying the treatment of Rheumatoid Arthritis, Lymphoma, Large B-Cell, Diffuse, and Leukemia Lymphocytic Chronic B-Cell. Reference standards of Spebrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Spebrutinib
Catalogue No.:PA 19 1730000
CAS :
Molecular Formula : C22H22FN5O3
Molecular Weight : 423.45
4-[[4-[[6-(Acryloyloxy)hexyl]oxy]benzoyl]oxy]phenyl 4-[(8-hydroxyoctyl)oxy]benzoate
Catalogue No.:PA 19 1731000
Molecular Formula : C37H44O9
Molecular Weight : 632.75
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
